x

60 DEGREES PHARMACEUTICALS, INC. (Nasdaq:SXTP)

N/A • N/A
CIK 1946563
Company

60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by Geoffrey Dow on September 9, 2010 and is headquartered in Washington, DC.

Address
N/A
Employees
None
Stock Info
Close
$0.3050
Day Range
0.2850 - 0.3198
52 Week Range
0.2580 - 8.6500
Average volume
776.43K
Short Interest
255.28K (02/15/24)
% of Float Shorted
7.77%
Market Cap
$3.21M
Revenue
N/A
Net Income
N/A
2020 Sales Growth
N/A
Rev. per Employee
$255.61K
P/E Ratio
N/A
EPS
N/A
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
SEC filings
DateFormEvent
18 Dec, 2024 4
9 Dec, 2024 4
21 Nov, 2024 4
14 Nov, 2024 10-Q
14 Nov, 2024 SC 13G
13 Nov, 2024 SC 13G/A
6 Nov, 2024 8-K
15 Oct, 2024 DEF 14A
8 Oct, 2024 8-K
2 Oct, 2024 PRE 14A
30 Sep, 2024 EFFECT
26 Sep, 2024 CORRESP
24 Sep, 2024 UPLOAD
19 Sep, 2024 S-3
11 Sep, 2024 4
6 Sep, 2024 8-K
28 Aug, 2024 8-K
14 Aug, 2024 10-Q
14 Aug, 2024 8-K
12 Aug, 2024 8-K
2 Aug, 2024 424B5
26 Jul, 2024 8-K
26 Jul, 2024 424B5
24 Jul, 2024 424B5
22 Jul, 2024 424B5
18 Jul, 2024 EFFECT
16 Jul, 2024 8-K
16 Jul, 2024 CORRESP
15 Jul, 2024 UPLOAD
12 Jul, 2024 S-3
9 Jul, 2024 8-K
27 Jun, 2024 8-K
12 Jun, 2024 8-K
30 May, 2024 DEF 14A
21 May, 2024 4
21 May, 2024 4
21 May, 2024 4
21 May, 2024 4
21 May, 2024 4
21 May, 2024 4
15 May, 2024 10-Q
7 May, 2024 SC 13G/A
3 May, 2024 PRE 14A
2 May, 2024 8-K
3 Apr, 2024 4
1 Apr, 2024 10-K
15 Mar, 2024 8-K
28 Feb, 2024 8-K
20 Feb, 2024 8-K
2 Feb, 2024 4
2 Feb, 2024 8-K
2 Feb, 2024 4
31 Jan, 2024 424B4
29 Jan, 2024 EFFECT
26 Jan, 2024 CORRESP
26 Jan, 2024 CORRESP
26 Jan, 2024 CORRESP
22 Jan, 2024 CORRESP
22 Jan, 2024 S-1
22 Jan, 2024 8-K
22 Jan, 2024 CORRESP
18 Jan, 2024 UPLOAD
16 Jan, 2024 8-K
12 Jan, 2024 DRS
18 Dec, 2023 3
18 Dec, 2023 SC 13G
20 Nov, 2023 10-Q
15 Nov, 2023 NT 10-Q
3 Nov, 2023 8-K
12 Oct, 2023 8-K
18 Sep, 2023 8-K
25 Aug, 2023 10-Q
17 Jul, 2023 8-K
13 Jul, 2023 424B4 IPO completed
12 Jul, 2023 4
12 Jul, 2023 4
12 Jul, 2023 CERT
11 Jul, 2023 3
11 Jul, 2023 3
11 Jul, 2023 3
11 Jul, 2023 SEC STAFF
11 Jul, 2023 3
11 Jul, 2023 3
11 Jul, 2023 EFFECT
11 Jul, 2023 3
11 Jul, 2023 3
11 Jul, 2023 3
11 Jul, 2023 3
7 Jul, 2023 CORRESP
7 Jul, 2023 CORRESP
27 Jun, 2023 8-A12B/A
27 Jun, 2023 CORRESP
27 Jun, 2023 CORRESP
27 Jun, 2023 CORRESP
22 Jun, 2023 CORRESP
16 Jun, 2023 CORRESP
16 Jun, 2023 CORRESP
14 Jun, 2023 8-A12B
14 Jun, 2023 8-A12B/A
14 Jun, 2023 CORRESP
12 Jun, 2023 CORRESP
12 Jun, 2023 CORRESP
8 Jun, 2023 S-1/A
8 Jun, 2023 CORRESP
6 Jun, 2023 UPLOAD
1 Jun, 2023 S-1/A
1 Jun, 2023 CORRESP
26 May, 2023 UPLOAD
24 May, 2023 D
19 May, 2023 S-1/A
19 May, 2023 CORRESP
8 May, 2023 UPLOAD
28 Apr, 2023 S-1/A
28 Apr, 2023 CORRESP
14 Apr, 2023 UPLOAD
14 Apr, 2023 SEC STAFF
3 Apr, 2023 S-1/A
3 Apr, 2023 CORRESP
8 Feb, 2023 UPLOAD
31 Jan, 2023 S-1
6 Jan, 2023 UPLOAD
23 Dec, 2022 DRSLTR
23 Dec, 2022 DRS/A
16 Dec, 2022 UPLOAD
5 Dec, 2022 DRS/A
5 Dec, 2022 DRSLTR
14 Nov, 2022 UPLOAD
18 Oct, 2022 DRS
Last update:2024-03-06 12:23:41.846678
60 DEGREES PHARMACEUTICALS, INC. by TradingView

Sign Up to Subscribe